News

← BACK TO NEWS

SOM Biotech aims to strengthen its communication and investor relations strategy with the support of Maqua Capital

Posted on July 24, 2019

As an essential part of SOM  Biotech´s strategy to strengthen its visibility within the investment community and with all its stakeholders, the company has hired the services of Maqua Capital, a consulting firm specialized in Investor Relations and Financial Communication. Maqua Capital will design and implement a strategic corporate communication and investor relations plan to ensure the consistency and effectiveness of SOM Biotech´s communication with all its stakeholders. Maqua Capital will work closely with SOM Biotech to develop a thorough understanding of SOM Biotech´s business and its unique value proposition. With this insight, SOM Biotech strives to effective communicate its investment thesis and to build an important momentum for the company’s investment story.